Your browser doesn't support javascript.
loading
Liver enzyme CYP2D6 gene and tardive dyskinesia.
Lu, Justin Y; Tiwari, Arun K; Freeman, Natalie; Zai, Gwyneth C; Luca, Vincenzo de; Müller, Daniel J; Tampakeras, Maria; Herbert, Deanna; Emmerson, Heather; Cheema, Sheraz Y; King, Nicole; Voineskos, Aristotle N; Potkin, Steven G; Lieberman, Jeffrey A; Meltzer, Herbert Y; Remington, Gary; Kennedy, James L; Zai, Clement C.
Afiliação
  • Lu JY; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, Toronto, ON, M5T 1R8, Canada.
  • Tiwari AK; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, Toronto, ON, M5T 1R8, Canada.
  • Freeman N; Department of Psychiatry, University of Toronto, Toronto, ON, M5T 1R8, Canada.
  • Zai GC; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, Toronto, ON, M5T 1R8, Canada.
  • Luca V; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, Toronto, ON, M5T 1R8, Canada.
  • Müller DJ; Department of Psychiatry, University of Toronto, Toronto, ON, M5T 1R8, Canada.
  • Tampakeras M; Institute of Medical Science, University of Toronto, Toronto, ON, M5S 1A8, Canada.
  • Herbert D; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, Toronto, ON, M5T 1R8, Canada.
  • Emmerson H; Department of Psychiatry, University of Toronto, Toronto, ON, M5T 1R8, Canada.
  • Cheema SY; Institute of Medical Science, University of Toronto, Toronto, ON, M5S 1A8, Canada.
  • King N; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, Toronto, ON, M5T 1R8, Canada.
  • Voineskos AN; Department of Psychiatry, University of Toronto, Toronto, ON, M5T 1R8, Canada.
  • Potkin SG; Institute of Medical Science, University of Toronto, Toronto, ON, M5S 1A8, Canada.
  • Lieberman JA; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, Toronto, ON, M5T 1R8, Canada.
  • Meltzer HY; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, Toronto, ON, M5T 1R8, Canada.
  • Remington G; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, Toronto, ON, M5T 1R8, Canada.
  • Kennedy JL; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, Toronto, ON, M5T 1R8, Canada.
  • Zai CC; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, Toronto, ON, M5T 1R8, Canada.
Pharmacogenomics ; 21(15): 1065-1072, 2020 10.
Article em En | MEDLINE | ID: mdl-32969762
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Citocromo P-450 CYP2D6 / População Branca / Discinesia Tardia / Fígado Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Pharmacogenomics Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Citocromo P-450 CYP2D6 / População Branca / Discinesia Tardia / Fígado Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Pharmacogenomics Ano de publicação: 2020 Tipo de documento: Article